MedPath
NMPA Approval

Insulin Aspart Injection

国药准字S20237016

December 14, 2023

国药准字S20210040

Drug Information

门冬胰岛素注射液

注射剂

3ml:300单位/支(预填充)

生物制品

December 14, 2023

Company Information

Applicant Company

吉林省通化县东宝新村

Manufacturing Company

吉林省通化县东宝新村

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬胰岛素注射液 - NMPA 批准文号 | MedPath